Thermo Fisher Scientific Profit Margin

The latest profit margin for TMO.NE is 14.96% as of September 2026. That compares with 15.02% in the prior-year period — down 0.4% year over year. That is above the Healthcare sector average of 9.48%. Investors often review this figure alongside Thermo Fisher Scientific's historical trend and sector peers before judging valuation or financial health.

Over the past year, TMO.NE's profit margin moved from 15.02% to 14.96% — a 0.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Thermo Fisher Scientific's valuation or profitability profile.

Against Healthcare companies, TMO.NE currently prints 14.96% for profit margin, while the sector average sits near 9.48%. That is roughly 57.8% above the sector mean. Large gaps often invite a closer look at Thermo Fisher Scientific's growth, margins, and balance sheet.

Profit Margin shows how effectively Thermo Fisher Scientific converts resources into returns. At 14.96%, TMO.NE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 15.02% in the prior-year period — down 0.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TMO.NE's profit margin (14.96%), review year-over-year change from 15.02%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.